S. 914 · 111th Congress
Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
SpecterSponsorNo cosponsors.
Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009 - Establishes the Cures Acceleration Network, an independent agency, to awards grants and contracts to eligible entities to accelerate the development of cures and treatments of diseases, including through the development of medical products and behavioral therapies.
What it does: CRS summary · Introduced in Senate · Apr 28, 2009
Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009 - Establishes the Cures Acceleration Network, an independent agency, to awards grants and contracts to eligible entities to accelerate the development of cures and treatments of diseases, including through the development of medical products and behavioral therapies. Defines "medical product" as a drug, device, biological product, or product that is a combination of drugs, devices, and biological products. Sets forth the functions of the Network.
Establishes the Cures Acceleration Network Review Board. Directs the Chairperson of the Board to award matching grants and contracts to eligible entities to: (1) accelerate the development of cures and treatments, including through the development of medical products, behavioral therapies, and biomarkers that demonstrate the safety or effectiveness of medical products; or (2) establish protocols that comply with the standards of the Food and Drug Administration (FDA) and otherwise meet regulatory requirements at all stages of development, manufacturing, review, approval, and safety surveillance of a medical product.
Sets forth provisions governing conflict of interest policies for the Network.
Amends the Public Health Service Act to rename the National Center on Minority Health and Health Disparities as the National Institute on Minority Health and Health Disparities.
Requires the Director of the National Institutes of Health (NIH) to develop and enforce NIH's conflict of interest policies and respond in a timely manner when such policies have been violated by a recipient of funds provided under a grant or contract.
Reauthorizes appropriations for NIH for FY2010-FY2012.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009
Latest action (Apr 28, 2009): Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4815-4817)
Policy area: Health · Origin: Senate · Introduced: Apr 28, 2009
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.